Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1

NCT02171819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A Subtype H5N1 Infection

Interventions

BIOLOGICAL: IVACFLU-A/H5N1, 7.5 mcg
BIOLOGICAL: IVACFLU-A/H5N1, 15 mcg
OTHER: Placebo Comparator

Sponsor

Institute of Vaccines and Medical Biologicals, Vietnam

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]